Name

ubl1

Label

Date participant was unblinded

Units
seconds from date of randomization
Type
integer
Visit Number vs Date participant was unblinded
N Mean StdDev Median Min Max Unknown Total
Baseline 11 12,143,127.3 ± 7,487,881.2 16,761,600.0 259,200.0 18,403,200.0 453 464
Follow-up 11 12,143,127.3 ± 7,487,881.2 16,761,600.0 259,200.0 18,403,200.0 442 453
Treatment Arm vs Date participant was unblinded
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 11 12,143,127.3 ± 7,487,881.2 16,761,600.0 259,200.0 18,403,200.0 442 453
Early adenotonsillectomy (EAT) 6 13,968,000.0 ± 7,006,537.5 17,971,200.0 1,555,200.0 18,403,200.0 220 226
Watchful waiting with supportive care (WWSC) 5 9,953,280.0 ± 8,235,103.0 13,651,200.0 259,200.0 17,193,600.0 222 227
Treatment Arm vs Date participant was unblinded
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 11 12,143,127.3 ± 7,487,881.2 16,761,600.0 259,200.0 18,403,200.0 442 453
Early adenotonsillectomy (EAT) 6 13,968,000.0 ± 7,006,537.5 17,971,200.0 1,555,200.0 18,403,200.0 220 226
Watchful waiting with supportive care (WWSC) 5 9,953,280.0 ± 8,235,103.0 13,651,200.0 259,200.0 17,193,600.0 222 227
Age vs Date participant was unblinded
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 11 12,143,127.3 ± 7,487,881.2 16,761,600.0 259,200.0 18,403,200.0 442 453
5 - 7 years old 8 10,983,600.0 ± 8,209,680.7 15,206,400.0 259,200.0 18,403,200.0 321 329
8 - 10 years old 3 15,235,200.0 ± 4,972,568.3 17,798,400.0 9,504,000.0 18,403,200.0 121 124
Age vs Date participant was unblinded
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 11 12,143,127.3 ± 7,487,881.2 16,761,600.0 259,200.0 18,403,200.0 388 399
5 - 7 years old 8 10,983,600.0 ± 8,209,680.7 15,206,400.0 259,200.0 18,403,200.0 254 262
8 - 10 years old 3 15,235,200.0 ± 4,972,568.3 17,798,400.0 9,504,000.0 18,403,200.0 134 137
Gender vs Date participant was unblinded
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 11 12,143,127.3 ± 7,487,881.2 16,761,600.0 259,200.0 18,403,200.0 442 453
Female 4 12,636,000.0 ± 7,386,863.2 15,422,400.0 1,900,800.0 17,798,400.0 230 234
Male 7 11,861,485.7 ± 8,118,491.8 16,761,600.0 259,200.0 18,403,200.0 212 219
Gender vs Date participant was unblinded
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 11 12,143,127.3 ± 7,487,881.2 16,761,600.0 259,200.0 18,403,200.0 442 453
Female 4 12,636,000.0 ± 7,386,863.2 15,422,400.0 1,900,800.0 17,798,400.0 230 234
Male 7 11,861,485.7 ± 8,118,491.8 16,761,600.0 259,200.0 18,403,200.0 212 219
Race vs Date participant was unblinded
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 11 12,143,127.3 ± 7,487,881.2 16,761,600.0 259,200.0 18,403,200.0 442 453
White 4 17,690,400.0 ± 841,753.6 17,798,400.0 16,761,600.0 18,403,200.0 152 156
Black 6 10,209,600.0 ± 7,758,011.2 11,577,600.0 259,200.0 18,144,000.0 243 249
Other 1 1,555,200.0 - 1,555,200.0 1,555,200.0 1,555,200.0 47 48
Race vs Date participant was unblinded
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 11 12,143,127.3 ± 7,487,881.2 16,761,600.0 259,200.0 18,403,200.0 442 453
White 4 17,690,400.0 ± 841,753.6 17,798,400.0 16,761,600.0 18,403,200.0 152 156
Black 6 10,209,600.0 ± 7,758,011.2 11,577,600.0 259,200.0 18,144,000.0 243 249
Other 1 1,555,200.0 - 1,555,200.0 1,555,200.0 1,555,200.0 47 48